Therapeutic Efficacy of Lu-177-CHX-A ''-DTPA-hu3S193 Radioimmunotherapy in Prostate Cancer Is Enhanced by EGFR Inhibition or Docetaxel Chemotherapy

Grants

Funding Acknowledgements

We thank the staff from the Department of Nuclear Medicine, Austin Hospital, for their assistance in the CT scanning and gamma camera imaging of animals and staff of the Tumour Targeting Program for assistance in biodistribution studies. This work was supported in part by an NH&MRC Program Grant No. 280912 and the Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research. MPK was supported by a Melbourne Research Scholarship, University of Melbourne, Melbourne, Australia. IDD is supported in part by a Victorian Cancer Agency Clinician Researcher Fellowship. MWB is supported by the Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research.